Certified by Founder
Lodge
Trogenix
start up
United Kingdom
- Edinburgh, Scotland
- 07/10/2025
- Series A
- $94,323,600
Precision genetic medicines, engineered for change
- Industry Biotechnology Research
- Website https://trogenix.com/
- LinkedIn https://www.linkedin.com/company/trogenixbio/
Related People
Ken MacnamaraFounder
United Kingdom -
Greater Edinburgh Area
Ken is the Chief Executive Officer of Trogenix, a biotech uniting cutting-edge technologies in genomics, oncology, immunotherapy, and gene therapy to create a revolutionary therapeutic approach.
Tribe Stays | $2,800,000 | (Nov 18, 2025)
No Barrier Medical Translation | $2,700,000 | (Nov 18, 2025)
PowerLattice | $25,000,000 | (Nov 18, 2025)
Shipday | $7,000,000 | (Nov 18, 2025)
Muse Software | $4,500,000 | (Nov 18, 2025)
Artios | $115,000,000 | (Nov 18, 2025)
Scripta Therapeutics | $12,000,000 | (Nov 18, 2025)
Self Labs | $9,000,000 | (Nov 18, 2025)
Obello | $8,500,000 | (Nov 18, 2025)
AlertD | $3,000,000 | (Nov 18, 2025)
Skeletalis, Inc. | $8,000,000 | (Nov 18, 2025)
Span(US) | $25,000,000 | (Nov 18, 2025)